a parallel, randomised, open-label clinical trial evaluating the safety and efficacy of methotrexate with apremilast in patients with moderate to severe palmoplantar psoriasis. Int. J. Pharm. Sci. Lett. 2020;10(1):29-39. Accessed October 13, 2026. https://ijpsl.org/index.php/ijpls/article/view/7